Previous studies have reported that a decrease in NCALD expression was associated with milder SMA phenotype (35), suggesting that the increased expression of NCALD is a detrimental compensatory mechanism to the loss of SMN. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.